Sleep disorders, such as Narcolepsy, have a substantial impact on individuals day to day living, influencing both their personal and professional lives. With the therapeutic advancements in a new potential treatments, including orexin2 receptor agonists, for sleep disorders, obtaining high-quality real-world evidence is critical to support clinical strategies, inform healthcare decisions, and demonstrate clinical and quality-of-life value to key stakeholders.
Adelphi Real World’s Disease Specific Programmes (DSPs) are purpose-built to address these challenges.
Our Narcolepsy provide comprehensive, real-world insights into treatment decision making and patient experiences. By engaging directly with sleep medicine specialists, patients, and caregivers, our DSPs deliver granular perspectives on:
Treatment Sequencing & Management Patterns
Understand real-world therapy selection, combination strategies, and sequential treatment approaches for patients with type 1 and type 2 narcolepsy.
Physician Decision-Making
Explore the physician reasoning behind treatment choices, factors influencing therapy selection in narcolepsy management.
Patient & Caregiver Experiences & Outcomes
Capture real-world efficacy, adherence, and satisfaction with treatment patient-reported lived experiences, including impact of narcolepsy on work, lifestyle and quality of life.
Emerging Unmet Needs
Uncover persistent treatment challenges, gaps in sleep disorder management, emerging therapeutic opportunities and treatment access barriers. Explore opportunities for therapeutic advancement to better support patients with narcolepsy.
Sleep Disorder Disease Specific Programmes (DSP) Portfolio
Why Partner With Adelphi Real World for Sleep Disorder Research?
Extensive Global Coverage
Our DSP network spans multiple countries, providing robust comparative insights into sleep medicine practice, treatment adoption, diagnostic approaches, and healthcare delivery across diverse healthcare systems.
Deep Clinical Expertise
With specialised knowledge of sleep disorders and narcolepsy, we ensure our data collection, analysis, and interpretation reflect the true complexity of sleep disease management and the needs of treating clinicians and patients.
Evidence That Drives Impact
From clinical development to reimbursement and healthcare provider engagement, our sleep disorder DSPs provide the credible, compelling evidence needed to influence decisions across the healthcare ecosystem.
Let’s Get Started
- Schedule a Consultation: Meet with our team to discuss how our DSPs can support your research, development, and market access objectives across Narcolepsy.
- Get More Details: Want to explore our methodology, global reach, patient insights, or specialist networks? We’re here to answer your questions and provide customised information
Adelphi Real World brings together real-world expertise, disease insight, and global reach to help you succeed in sleep medicine research. Let’s collaborate to advance evidence and improve outcomes for patients with sleep disorders.
Contact us today using the form below.
Conferences Attending
Observational Research